163 related articles for article (PubMed ID: 35221802)
21. Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.
Sumita Y; Yamazaki M; Maruyama S; Abé T; Cheng J; Takagi R; Tanuma JI
Oncol Rep; 2018 Nov; 40(5):2487-2496. PubMed ID: 30132562
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA
Zhao H; Xiao H; Lu Y; Liu S; Wang C
Cell Cycle; 2020 May; 19(10):1143-1157. PubMed ID: 32308105
[TBL] [Abstract][Full Text] [Related]
23. Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer.
Wan YP; Xi M; He HC; Wan S; Hua W; Zen ZC; Liu YL; Zhou YL; Mo RJ; Zhuo YJ; Luo HW; Jiang FN; Zhong WD
Oncol Res Treat; 2017; 40(1-2):15-20. PubMed ID: 28118628
[TBL] [Abstract][Full Text] [Related]
24. Elevated expression of SOX9 is related with the progression of gastric carcinoma.
Zhou CJ; Guo JQ; Zhu KX; Zhang QH; Pan CR; Xu WH; Wang HJ; Liu B
Diagn Cytopathol; 2011 Feb; 39(2):105-9. PubMed ID: 20301211
[TBL] [Abstract][Full Text] [Related]
25. Myeloid cell leukemia-1 as a candidate prognostic biomarker in cancers: a systematic review and meta-analysis.
Wang J; He Y; Yang C; Luo Q; Wang B
Expert Rev Anticancer Ther; 2023; 23(9):1017-1027. PubMed ID: 37467344
[TBL] [Abstract][Full Text] [Related]
26. Biological and clinical implications of endocan in gastric cancer.
Zhao W; Sun M; Li S; Wang Y; Liu J
Tumour Biol; 2014 Oct; 35(10):10043-9. PubMed ID: 25012244
[TBL] [Abstract][Full Text] [Related]
27. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment.
Fan Y; Li Y; Yao X; Jin J; Scott A; Liu B; Wang S; Huo L; Wang Y; Wang R; Pool Pizzi M; Ma L; Shao S; Sewastjanow-Silva M; Waters R; Chatterjee D; Liu B; Shanbhag N; Peng G; Calin GA; Mazur PK; Hanash SM; Ishizawa J; Hirata Y; Nagano O; Wang Z; Wang L; Xian W; McKeon F; Ajani JA; Song S
Gut; 2023 Apr; 72(4):624-637. PubMed ID: 36002248
[TBL] [Abstract][Full Text] [Related]
28. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
Tang C; Gao X; Liu H; Jiang T; Zhai X
Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
[TBL] [Abstract][Full Text] [Related]
29. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival.
Zhou CH; Ye LP; Ye SX; Li Y; Zhang XY; Xu XY; Gong LY
J Exp Clin Cancer Res; 2012 Mar; 31(1):18. PubMed ID: 22385677
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer.
Chakravarty G; Moroz K; Makridakis NM; Lloyd SA; Galvez SE; Canavello PR; Lacey MR; Agrawal K; Mondal D
Exp Biol Med (Maywood); 2011 Feb; 236(2):145-55. PubMed ID: 21321311
[TBL] [Abstract][Full Text] [Related]
32. TRIM15 Exerts Anti-Tumor Effects Through Suppressing Cancer Cell Invasion in Gastric Adenocarcinoma.
Chen W; Lu C; Hong J
Med Sci Monit; 2018 Nov; 24():8033-8041. PubMed ID: 30412518
[TBL] [Abstract][Full Text] [Related]
33. Low expression of CDK5RAP3 and DDRGK1 indicates a poor prognosis in patients with gastric cancer.
Lin JX; Xie XS; Weng XF; Zheng CH; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Huang CM
World J Gastroenterol; 2018 Sep; 24(34):3898-3907. PubMed ID: 30228783
[TBL] [Abstract][Full Text] [Related]
34. SOX9 Elevation Acts with Canonical WNT Signaling to Drive Gastric Cancer Progression.
Santos JC; Carrasco-Garcia E; Garcia-Puga M; Aldaz P; Montes M; Fernandez-Reyes M; de Oliveira CC; Lawrie CH; Araúzo-Bravo MJ; Ribeiro ML; Matheu A
Cancer Res; 2016 Nov; 76(22):6735-6746. PubMed ID: 27569216
[TBL] [Abstract][Full Text] [Related]
35. Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.
Chang Y; Niu W; Lian PL; Wang XQ; Meng ZX; Liu Y; Zhao R
World J Gastroenterol; 2016 Jun; 22(23):5422-9. PubMed ID: 27340359
[TBL] [Abstract][Full Text] [Related]
36. Lin28B is a novel prognostic marker in gastric adenocarcinoma.
Hu Q; Peng J; Liu W; He X; Cui L; Chen X; Yang M; Liu H; Liu S; Wang H
Int J Clin Exp Pathol; 2014; 7(8):5083-92. PubMed ID: 25197381
[TBL] [Abstract][Full Text] [Related]
37. MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker.
Giaginis C; Giagini A; Tsourouflis G; Gatzidou E; Agapitos E; Kouraklis G; Theocharis S
Dig Dis Sci; 2011 Mar; 56(3):777-85. PubMed ID: 20694513
[TBL] [Abstract][Full Text] [Related]
38. Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma.
Xia S; Feng Z; Qi X; Yin Y; Jin J; Wu Y; Wu H; Feng Y; Tao M
Med Oncol; 2015 Jan; 32(1):358. PubMed ID: 25428381
[TBL] [Abstract][Full Text] [Related]
39. Multicenter large-scale study of prognostic impact of HER2 expression in patients with resectable gastric cancer.
Kurokawa Y; Matsuura N; Kimura Y; Adachi S; Fujita J; Imamura H; Kobayashi K; Yokoyama Y; Shaker MN; Takiguchi S; Mori M; Doki Y
Gastric Cancer; 2015 Oct; 18(4):691-7. PubMed ID: 25224659
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
